Nathaniel Marchetti, DOEnriched profile
Professor of Thoracic Medicine and Surgery; Vice Chair for Clinical Affairs, Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University; Medical Director, Respiratory Intensive Care Unit, Temple University Hospital · Lewis Katz School of Medicine at Temple University / Temple University Hospital (Temple Lung Center)
Overview
Updated 14 Jul 2026
Nathaniel Marchetti, DO, is Professor of Thoracic Medicine and Surgery at Lewis Katz School of Medicine at Temple University / Temple University Hospital (Temple Lung Center). The public record shows 254 publications with 6,851 citations (h-index 36), centered on COPD. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 9 companies, 2 NIH-funded awards (2018–2024).
- Most recent indexed publication: 2026 · Pulmonary circulation
- Top research focus: COPD
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Sponsor: Johns Hopkins University
InvestigatorPhase 2RecruitingNCT07059091 - Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Sponsor: Apreo Health, Inc.
InvestigatorRecruitingNCT06891755 - Biological Effects of Quercetin in COPD Phase II
Sponsor: Temple University
InvestigatorPhase 2UnknownNCT06003270
Industry payments
Updated 14 Jul 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
- Chiesi USA, Inc.Program year20252 payments
- CSL BehringProgram year20251 payment
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2018–2024 per NIH RePORTER. The latest:
- Impact of quercetin on inflammatory and oxidative stress markers in COPD
Temple Univ of the Commonwealth
FY2024$371,479R33AT009991 - Impact of quercetin on inflammatory and oxidative stress markers in COPD
Temple Univ of the Commonwealth
FY2023$375,403R33AT009991 - Impact of quercetin on inflammatory and oxidative stress markers in COPD
Temple Univ of the Commonwealth
FY2022$386,229R33AT009991
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Anabolic Medications for Muscle Wasting in Chronic Obstructive Pulmonary Disease. Is the Evidence Getting Stronger?
American journal of respiratory and critical care medicine
2019
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Temple Lung Center, 3401 N. Broad St, Ambulatory Care Center, 5th Floor, Philadelphia, PA 19140
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- DO
Philadelphia College of Osteopathic Medicine, Philadelphia, PA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗ - American Board of Internal Medicine - Board Certified
Pulmonary Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗ - American Board of Internal Medicine - Board Certified
Critical Care Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
- First Place
Annual Sol Sherry Resident and Fellow Research Conference
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
Secondary affiliationsappointments beyond the home institution
- Principal Investigator
American Lung Association Airways Clinical Research Centers (ACRC) network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/cv/nathaniel-marchetti-do-1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Other
hcplive.com/authors/nathaniel-marchetti-do
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗ - Other
lung.org/research/airways-clinical-research-centers/investigators/nathaniel-marchetti
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗ - Other
templehealth.org/about/news/in-the-media/dr-nathaniel-marchetti-offers-commentary-to-medscape-on-new-study-testing-wearable-tech-for-copd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.